These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8239590)

  • 21. [Susceptibility to macrolides against Mycoplasma pneumoniae isolated during 7 years].
    Arai S; Ohishi M; Shigematsu H
    Kansenshogaku Zasshi; 1994 Feb; 68(2):201-8. PubMed ID: 8151146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
    Clement JJ; Tanaka SK; Alder J; Vojtko C; Beyer J; Hensey D; Ramer N; McDaniel D; Chu DT
    Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Antimicrobial Susceptibilities among
    Oishi T; Takahashi K; Wakabayashi S; Nakamura Y; Ono S; Kono M; Kato A; Saito A; Kondo E; Tanaka Y; Teranishi H; Akaike H; Tanaka T; Miyata I; Ogita S; Ohno N; Nakano T; Ouchi K
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
    Cohen MA; Huband MD
    J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further characterization of the in vitro and in vivo activity of ciprofloxacin against mycoplasmas.
    Furneri PM; Tempera G; Chiarenza A; Caccamo F; Speciale AM; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):346-9. PubMed ID: 3123079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oxytetracycline and erythromycin on Syrian hamsters after intratracheal infection with Mycoplasma pneumoniae.
    Ritter E; Lange A; Rockel C; Ortel J
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):83-9. PubMed ID: 3106470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
    Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
    Kim JH; Kang JA; Kim YG; Kim JW; Lee JH; Choi EC; Kim BK
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2209-13. PubMed ID: 9333049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of temafloxacin against respiratory pathogens.
    Swanson RN; Hardy DJ; Chu DT; Shipkowitz NL; Clement JJ
    Antimicrob Agents Chemother; 1991 Mar; 35(3):423-9. PubMed ID: 2039192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
    Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
    Ito T; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
    Ozaki M; Matsuda M; Tomii Y; Kimura K; Segawa J; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae.
    Hannan PC; Windsor HM; Ripley PH
    Res Vet Sci; 1997; 63(2):157-60. PubMed ID: 9429250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential improvements in therapeutic options for mycoplasmal respiratory infections.
    Bébéar C; Dupon M; Renaudin H; de Barbeyrac B
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S202-7. PubMed ID: 8399917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.
    Lister PD; Sanders CC
    Antimicrob Agents Chemother; 1999 May; 43(5):1118-23. PubMed ID: 10223923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.
    Ishida Y; Kurosaka Y; Murakami Y; Otani T; Yamaguchi K
    Chemotherapy; 1999; 45(3):183-91. PubMed ID: 10224340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
    Jones RN; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):119-26. PubMed ID: 9823536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.